Fundraising FoxHydra Biosciences
Cambridge, US · Delaware LLC · 5 known investors
Find your way into Hydra Biosciences
Sign up to find every way you can get introduced to Hydra Biosciences
- Your email: who you already know at Hydra Biosciences, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Hydra Biosciences team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
MM
Magdalene Moran, Ph.D.Executive
BC
Bert Chenard, Ph.D.Executive
RH
Russell HerndonExecutive
TB
Tom BurkeExecutive
Board
VM
Vincent MilesBoard director
JG
PG
Paul GoldenheimBoard director
RC
Robert CarpenterBoard director
SE
Steven E. HallBoard director
Investors · 5
Lightstone Ventureslisted by Lightstone VenturesPortola Valley
How we know: Lightstone Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Saints Capitallisted by Saints CapitalSan Francisco
How we know: Saints Capital's portfolio page · Not right? Tell us
AbingworthreportedLondon · $15M – $30M
How we know: a partner's Signal profile · Not right? Tell us
Lilly Venturesreported
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$10.5M disclosed across 2 rounds · 2015–2019
▶$1raisedJun 2019 · 97 investors · BiotechnologyRule 506(b)
▶$1raisedJun 2019 · 97 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Russell HerndonExecutive Officer, Director
- Robert CarpenterDirector
- Vincent MilesDirector
- Steven HallDirector
- Paul GoldenheimDirector
- Offering amount
- $1
- Amount sold
- $1
- First sale
- May 2019
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$10.5MraisedMar 2015 · 7 investors · BiotechnologyRule 506(b)
▶$10.5MraisedMar 2015 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul GoldenheimDirector
- Magdalene Moran, Ph.D.Executive Officer
- Bert Chenard, Ph.D.Executive Officer
- Vincent MilesDirector
- Russell HerndonExecutive Officer, Director
- Robert CarpenterDirector
- Jean GeorgeDirector
- Tom BurkeExecutive Officer
- Steven E. HallDirector
- Offering amount
- $17.7M
- Amount sold
- $10.5M
- First sale
- Mar 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Hydra Biosciences went on to found or lead other companies.
Frequently asked questions
- Who are Hydra Biosciences's investors?
- Hydra Biosciences's investors include Lightstone Ventures, New Enterprise Associates (NEA), Saints Capital, Abingworth, Lilly Ventures.
- How much funding has Hydra Biosciences raised?
- Hydra Biosciences has disclosed $10.5M raised across 2 rounds.
- Where is Hydra Biosciences headquartered?
- Hydra Biosciences is headquartered in Cambridge, US.